Urolithiasis, Calcium Oxalate
8
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
A Single-Center Clinical Study on the Efficacy and Safety of VISOR
Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
What Lies Beneath the Stone? Metabolic Insights From Composition-Based Analysis of Kidney Stones
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
Comparison of Trifecta Analysis of Standard Versus Mini Percutaneous Nephrolithotomy in the Management of Urolithiasis
Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract